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Purpose: To investigate the antipyretic activity of the methanol extract of Bombax malabaricum leaves 
(MEBM) in rats.  
Methods: Baker’s yeast was used to induce fever in Wistar rats which were divided into four groups. 
The animal groups were thereafter administered MEBM (200 mg/kg), MEBM (400 mg/kg), paracetamol 
(reference standard, 150 mg/kg) and 1 % Tween 80 (control), respectively. The body temperature of the 
rats was measured rectally over a period of 8 h. MEBM was also phytochemically screened for 
alkaloids, steroids, carbohydrates, tannins, fixed oils, proteins, triterpenoids, deoxy-sugar, flavonoid, 
cyanogenetic and coumarin glycosides. 
Results: MEBM (200 mg/kg and 400 mg/kg) significantly reduced yeast-induced pyrexia (p < 0.05, p < 
0.01, respectively). Phytochemical tests showed the presence of steroids, carbohydrates, tannins, 
triterpenoids, deoxy-sugars, flavonoids and coumarin glycosides.  
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INTRODUCTION 
 
Fever is a common medical symptom 
associated primarily with elevation of body 
temperature and is often accompanied by 
certain sickness-related behavioural features 
such as depression, sleepiness, lethargy, 
hyperalgesia, anorexia, etc. A number of 
disease conditions such as infections, skin 
inflammation, immunological disorders, tissue 
destruction, cancer, metabolic disorders, and 
reaction to incompatible blood products, 
usually accompany fever [1]. Mechanistically, 
the hypothalamus of the brain controls the 
heat effector mechanism via the autonomic 
nervous system, either by increase of heat 
production (through increased muscle tone or 
shivering) or prevention of heat loss by 
vasoconstriction [1]. There is controversy 
regarding the usefulness of fever; however, 
high temperature is always considered a 
medical emergency due to its serious side 
effects such as intracranial haemorrhage, 
sepsis, Kawasaki syndrome, thyroid storm, 
and serotonin syndrome [1].  
 
The search for an ideal antipyretic drug is a 
never-ending challenge. Paracetamol and 
other popular synthetic antipyretic drugs have 
several side effects [2]. Therefore, it is worth 
searching for herbal materials that are 
equally efficacious but less toxic and 
comparatively free from side effects, as 
substitutes for synthetic drugs such as 
paracetamol. 
 
The plant, Bombax malabaricum DC. (silk 
cotton tree) {Synonym: Bombax ceiba L.; 
Salmalia malabaricum Schott & Endl.}, 
belongs to the family Bombacaceae. It has 
been shown to be important in traditional 
medicine [3]. It is a lofty deciduous tree of up 
to 40 meters in height; its young stems and 
branches are covered with stout, hard 
prickles; its leaves are large, spreading, 
glabrous and digitate; leaflets are 5-7, 
lanceolate and 10-20 cm long; its flowers 
numerous, large, fleshy, bright crimson, 
yellow or orange, clustered at the end of the 
branches while its capsules are oblong-ovoid, 
containing many seeds with long, dense silky 
hairs. It is found in the tropical and 
subtropical regions of the world. The plant is 
economically important as a source of cotton 
and timber, including its use for the 
production of match-sticks. [3].  
 
The leaves are used traditionally in 
inflammation and cutaneous trouble [3,4]. Its 
leaf extract exhibits significant antifungal 
activities against ringworm infection while the 
bark gum contains catechutannic acid [5]. 
Dar et al [6] isolated antioxidant and 
analgesic mangiferin from the leaves of the 
plant. The root contains bombamalones A-D, 
bombamaloside, isohemigossypol- 1-methyl 
ester, 5,2-O-methylisohemigossylic acid 
lactone, 6-bombaxquinone B and lacinilene C 
[7] while the petal contains orange-red 
anthocyanin pelargonidin-5-β-D-glucopyrano-
side and cyanidine-7-methyl ether-3 β-
glucopyranoside. The root-bark contains 
lupeol, β-sitosterol, 8-formyl-7-hydroxy-5-
isopropyl-2-methoxy-3-methyl-1,4-napthaqui-
none, isohemiglogossyol-1-methyl ether and 
7-hydroxycadalene [3]. Lupeol, β-sitosterol 
and β-sitosterol-D-glucoside have been 
isolated from its stem bark while lupeol, β-
sitosterol and two naphthaqinones were 
obtained from the root bark of the plant [8]. 
 
To the best of our knowledge, there is no 
report on the antipyretic activity of the 
methanol extract of the leaves of Bombax 
malabaricum. The purpose of the present 
work, therefore, was to investigate the 
methanol extract of Bombax malabaricum 
leaves (MEBM) for its antipyretic activity. 
Phytochemical screening of the extract was 




Chemicals and reagents 
 
Methanol was obtained from CDH, India. 
Paracetamol was obtained from 
GlaxoSmithKline, India. Other chemicals and 
reagents used were of analytical grade. 
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Plant material 
 
The fresh leaves of Bombax malabaricum 
were collected from the city of Azamgarh, 
Uttar Pradesh, India during the month of May 
2008 and were identified by Dr HJ 
Chowdhery, a taxonomist and Joint Director, 
Central National Herbarium (CNH), Botanical 
Survey of India, Howrah, India The voucher 
specimen (no. CNH/1-I(314)/2009-Tech 
II/356/346) was deposited in the herbarium of 
CNH, Botanical Survey of India, Howrah, 
India for future reference. The leaves were 
dried under the shade, powdered and then 
stored in an air-tight container prior to use. 
 
Preparation of extract 
 
The powdered leaves were extracted in a 
Soxhlet apparatus using methanol as solvent. 
The solvent was removed from the extract in 
a rotary vacuum evaporator and the extract 
subsequently dried in a vacuum oven at 45 
0
C to obtain a solid mass of the crude extract 
which was kept in a desiccator prior to use in 
the animal studies.  
 
Preliminary phytochemical screening 
 
Preliminary phytochemical screening for 
alkaloids, steroids, carbohydrates, tannins, 
fixed oils, proteins, triterpenoids, deoxy-
sugar, flavonoid, cyanogenetic and coumarin 
glycosides carried out on the extract 
according to the procedures of Khandelwal 
[9]. Test for alkaloids carried out using 
Mayer’s, Dragendorff’s, Wagner’s and 
Hager’s reagents. Presence of steroid was 
confirmed with Libermann-Burchard, 
Salkowski, and Libermann’s reactions. Test 
for carbohydrate was undertaken using 
Fehling’s, Benedict’s, Molish’s, Tollen’s and 
iodine tests. Keller-Killiani test was done to 
confirm the presence of deoxy-sugar. Noller’s 
reagent was used to test for triterpenoids. 
Shinoda and Wolform tests were used for the 
identification of flavonoids. The presence of 
tannins was determined by reaction with 5% 
ferric chloride, acetic acid, lead acetate, 
gelatin, dilute potassium permanganate, 
potassium dichromate solution, bromine 
water and dilute nitric acid. For cyanogenetic 
glycoside, Guignard reaction was used 
whereby a filter paper strip was soaked in 10 
% picric acid and 10 % sodium carbonate, 
respectively. It was kept in the slit of a cork 
over the moistened extract in a conical flask. 
Brick red or maroon colour confirms the 
positive test for cyanogenetic glycosides. 
Blue or green fluorescence indicates a 
positive test for coumarin glycosides when 
the alcoholic extract is rendered alkaline. The 
extract was tested for protein using biuret and 
ninhydrin tests and also by reacting with 
Million’s reagent. The presence of fixed oils 




Wister rats of either sex and weighing 120 - 
130 g were used for the antipyretic test. The 
animals were kept under controlled 
conditions (temperature, 25 ± 2 
0
C; light/dark 
cycle, 12/12 h) and fed with standard pellet 
diet and water ad libitum. The study received 
prior approval from the Institutional Animal 
Ethical Committee, Pharmacy College, 
Azamgarh, India (approval reference no. 
937/c/06/CPCSEA). Animal handling was 
followed the guidelines of the Committee for 
the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA) [10]. 
 
Preparation of extract for animal studies 
 
The crude extract (MEBM, 600 mg) was 
suspended in 1 % aqueous Tween 80 (15 
ml). Control treatment was with 1 % Tween 
80 while the reference standard was 
paracetamol (250 mg) suspended in 1% 
Tween 80 (17 ml). 
 
Induction of pyrexia 
 
Antipyretic activity was measured by slightly 
modifying the method described by Dewan et 
al [11]. The rats were divided into four groups 
of six animals each. Rectal temperature was 
measured by introducing a 3 cm digital 
thermometer (Model MT-101, N & B Medical, 
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Delhi) coated with glycerin (lubricant) into the 
rectum. Pyrexia (10 ml/kg) was induced by 
intra-subcutaneous injection of 20 % Baker’s 




Four hours after yeast injection, the animal 
groups received orally MEBM (400 mg/kg or 
200 mg/kg), paracetamol (reference standard 
(150 mg/kg) and 1 % Tween 80 (control), 
respectively. Body temperature was 





All the results are expressed as the mean ± 
S.E.M. The data were analyzed for statistical 
significance by one-way analysis of variance 
(ANOVA) followed by Tukey test using 
computerized GraphPad Prism, version 4.03 
software (Graph Pad Software Inc). Values of 







The outcome of the preliminary 
phytochemical screening of the extract 
showed the presence of steroids, 
carbohydrates, tannins, triterpenoids, deoxy-




Administration of Baker’s yeast produced an 
increase in the body temperature of the rats 
from normal (37.66 ± 0.02 
0
C) to 38.69 ± 0.03 
0
C within four hours of yeast injection. Fig 1 
shows that maximum temperature was 
attained in the control group at 1 h (i.e., 5 h 
after yeast administration) with a value of 
39.2 ± 0.04 
0
C. MEBM (200 mg/kg, 400 
mg/kg) and paracetamol reduced the body 
temperature to 38.17 ± 0.05 
0
C, 37.97 ± 0.05 
0
C and 37.91 ± 0.05 
0
C, respectively after 6 
h. MEBM’s antipyretic activity at doses of 200 
mg/kg (p < 0.05) and 400 mg/kg (p < 0.01) 
was higher than that of control. However, the 
standard drug, paracetamol 150 mg/kg 
demonstrated the excellent antipyretic activity 
(p < 0.001) compared with that of control. 
After 8 h, body temperature in the MEBM-
treated groups (200 and 400 mg/kg) 
remained essentially unchanged at 38.21 ± 












































  *p  < 0.05  
 **p < 0.01 
***p  < 0.001
 
Figure 1: Antipyretic effect of MEBM on Baker’s 
yeast-induced pyrexia in rats (♦ = control;   = MEBM 
200 mg/kg;  ▲ = MEBM 400 mg/kg;  Ο = paracetamol 




The present study showed that the methanol 
extract of Bombax malabaricum (MEBM) 
possessed significant antipyretic activity in 
Baker’s yeast-induced pyrexia. The standard 
(paracetamol) achieved maximum antipyretic 
activity in 3 h; its activity decreased 
subsequently probably due to metabolism 
and excretion of the drug. On the other hand, 
maximum antipyretic activity for MEBM 
occurred at 6 h, indicating slow but steady 
absorption of the drug from the GIT; this may 
have been responsible for the prolonged 
action of the extract. Subsequently, up to the 
8
th
 hour, its activity remained largely 
unchanged. The antipyretic activity of the 
extract was dose-dependent with the higher 
dose producing greater activity.  
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The hypothalamus regulates body 
temperature with a delicate balance between 
heat production and heat loss through the 
set-point control. Infection, tissue damage, 
inflammation, graft rejection, malignancy and 
several other ill-health conditions may elevate 
the set point to induce fever [12]. When the 
set point is raised, enhancement of the body 
temperature takes place through active 
generation and retention of heat. 
Vasoconstriction also helps to reduce heat 
loss through skin. In this way, the body 
matches the brain blood temperature with the 
new set point made by the hypothalamus [1]. 
Biochemically, during fever, enhanced 
formation of cytokines such as interleukins 
(IL-1α, IL-1β, IL-6 and IL-6), interferon (α, β), 
tumour necrosis factor alpha (TNF-α) takes 
place under such physiological conditions 
[12]. These cytokine factors migrate to 
circumventricular organs of the brain and 
bind with endothelial receptors on vessel 
walls or interact with local microglial cells. 
After binding, it activates the arachidonic acid 
pathway which enhances the synthesis of 
prostaglandin E2 (PGE2). The pathway 
consists of the enzymes phospholipase A2, 
cyclo-oxygenase-2 (COX-2) and prostaglan-
din E2 synthase, which are responsible for 
the synthesis and release of PGE2. PGE2 is 
the final mediator for febrile response. The 
set point temperature of the body remains 
elevated until PGE2 is present in the 
hypothalamus [1]. Again, PGE2 triggers the 
hypothalamus for more formation of heat by 
minimizing heat loss through cyclic 
adenosine mono-phosphate (cAMP) 
pathways [12]. It has been established that 
yeast induces pathogenic fever in rat by 
enhancing the production of prostaglandins, 
mainly PGE2, which elevates the set point of 
the thermoregulatory centre in hypothalamus 
[13]. 
 
Paracetamol possesses potent antipyretic 
and analgesic activities with minimal anti-
inflammatory activity. It may selectively inhibit 
specific COX isoform in the CNS to inhibit 
prostaglandin synthesis to achieve its 
antipyretic effect [14] but does not influence 
body temperature when it is elevated by 
factors such as exercise or increase in 
ambient temperature [12]. Certain 
phytochemical compounds such as steroids, 
carbohydrates, tannins, triterpenoids, 
flavonoid and coumarin glycosides were 
found to be present in the extract during 
phytochemical screening. The antipyretic 
potentials of steroids, tannins, triterpenoids, 
flavonoid and coumarin glycosides have been 
reported in various studies [15-18]. 
Therefore, the antipyretic activity of MEBM 
may be due to its contents of steroids, 
tannins, triterpenoids, flavonoid and coumarin 
glycosides. 
 
Furthermore, indirect evidence seems to 
support the influence of MEBM on the 
biosynthesis of prostaglandin (PGE2) which is 
a regulator of body temperature; this may 
also partly account for its antipyretic activity 




The results obtained demonstrate the 
significant antipyretic activity of the methanol 
extract of Bombax malabaricum leaves. 
Inhibition of the synthesis and/or release of 
inflammatory mediators may be its main 
mechanism(s) of action. These results also 
suggest that the presence of certain bioactive 
molecules may partly be responsible for the 
reported antipyretic activity of MEBM, the 
isolation of which could help to obtain 
improved antipyretic drugs with specific 
mechanism of action. Further 
experimentation is under way in our 
laboratory to isolate the active molecules 
from MEBM and to establish the exact 
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